Join Black Lake Capital in supporting the Leukemia and Lymphoma Society

Black Lake Capital is proud to support the Leukemia and Lymphoma Society (LLS). Since Chad lost his father to acute myeloid leukemia in 2019, we have raised over $250K for this life-saving organization. LLS has funded 54 of the 64 blood cancer treatments approved by the FDA since 2017, 40% of all cancer drugs approved by the FDA since 2000 were initially approved for blood cancer.

This year, Chad's 16-year-old son Locke is participating in LLS's Student Visionary of the Year campaign. His team Lockedown Leukemia, is competing against others in Colorado to raise as much as they can to stop blood cancer in its tracks. You can support Locke's team at https://events.lls.org/rm/svoydenver24/lscripps.

About Black Lake Capital
Black Lake Capital is a private investment firm partnering with technology and innovation-enabled businesses. From 100% buyouts to equity recapitalizations with majority or substantial minority positions, Black Lake has the flexibility to meet the needs of growing businesses. On our ten-year history, we have completed 14 transactions in cybersecurity, software development, systems integration, managed services, supply chain, and technology distribution Please visit our website, www.blacklakecap.com, for more information.